- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplatic Syndrome in United Kingdom
Total 14266 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMyelodysplastic SyndromeUnited States
-
Massachusetts General HospitalNovartisRecruiting
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Janssen Research & Development, LLCActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited Kingdom, France, Korea, Republic of, Spain
-
University of NebraskaNational Cancer Institute (NCI)TerminatedMyelodysplastic SyndromesUnited States
-
Ehab L AtallahCompleted
-
NovaceaUnknownMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic Syndrome With Isolated Del(5q)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome/Acute Myeloid LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownMyelodysplastic Syndromes | AdultBelgium, United States, Austria, United Kingdom, Italy, Taiwan, Brazil, China, Croatia, Czechia, France, Germany
-
Brian JonasPharmacyclics LLC.CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in TransformationUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Washington University School of MedicineAmerican Society of HematologyRecruitingMyelodysplastic Syndromes | Whole Genome SequencingUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
Millennium Pharmaceuticals, Inc.CompletedAcute Myelogenous Leukemia | High-Grade Myelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromesUnited States, France, Germany
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
University of RochesterNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Myeloid Malignancy | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsTerminatedMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Hoffmann-La RocheCompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
Office of Rare Diseases (ORD)Rare Diseases Clinical Research NetworkUnknownMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisRecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterGlaxoSmithKline; NovartisCompleted
-
Duke UniversityBayerTerminatedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Rush University Medical CenterCelgene CorporationTerminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminated
-
M.D. Anderson Cancer CenterS*BIOTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic SyndromeUnited States